Balance Sheet
Accounts PayablesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AdaptHealth (AHCO) Capital Leases (2018 - 2025)

AdaptHealth has reported Capital Leases over the past 7 years, most recently at $32.6 million for Q4 2025.

  • For Q4 2025, Capital Leases rose 32.38% year-over-year to $32.6 million; the TTM value through Dec 2025 reached $32.6 million, up 32.38%, while the annual FY2025 figure was $32.6 million, 32.38% up from the prior year.
  • Capital Leases for Q4 2025 was $32.6 million at AdaptHealth, up from $24.6 million in the prior quarter.
  • Over five years, Capital Leases peaked at $32.6 million in Q4 2025 and troughed at $132000.0 in Q4 2021.
  • A 5-year average of $16.8 million and a median of $19.2 million in 2023 define the central range for Capital Leases.
  • Biggest five-year swings in Capital Leases: soared 2892.42% in 2022 and later rose 8.28% in 2024.
  • Year by year, Capital Leases stood at $132000.0 in 2021, then soared by 2892.42% to $4.0 million in 2022, then soared by 475.85% to $22.7 million in 2023, then increased by 8.28% to $24.6 million in 2024, then soared by 32.38% to $32.6 million in 2025.
  • Business Quant data shows Capital Leases for AHCO at $32.6 million in Q4 2025, $24.6 million in Q4 2024, and $26.1 million in Q3 2024.